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Attending to and understanding one’s own feelings are components of meta-mood and
constitute important socio-affective skills across the entire lifespan. Growing evidence
suggests a modulatory role of the neuropeptide oxytocin on various socio-affective
processes. Going beyond previous work that almost exclusively examined young men
and perceptions of emotions in others, the current study investigated effects of intranasal
oxytocin on meta-mood in young and older men and women. In a double-blind between-
group design, participants were randomly assigned to self-administer either intranasal
oxytocin or a placebo before responding to items from the Trait Meta-Mood Scale
(TMMS) about attention to feelings and clarity of feelings. In contrast to older women,
oxytocin relative to placebo increased attention to feelings in older men. Oxytocin
relative to placebo enhanced meta-mood in young female participants but reduced it
in older female participants. This pattern of findings supports an age- and sex-differential
modulatory function of the neuropeptide oxytocin on meta-mood, possibly associated
with neurobiological differences with age and sex.
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Introduction
There is growing evidence that the neuropeptide oxytocin functions within the social and affective
systems of animals and humans as a key neuromodulator involved in the synchronization of body
and brain in the coordination of a wide spectrum of behavioral, physiological, and psychological
responses across a variety of life circumstances (Panksepp, 2009; Meyer-Lindenberg et al., 2011). In
particular, oxytocin appears to promote social approach and reduce anxiety, possibly by increasing
salience of socio-affective information and augmenting reward neural circuits (De Dreu, 2014).
This neural model is supported by evidence that brain regions such as the amygdala and nucleus
accumbens that are associated with socio-affective and reward processing are particularly sensitive
to oxytocin (Gimpl and Fahrenholz, 2001; Balleine et al., 2007).
It has been proposed that oxytocin may primarily affect lower brain mechanisms and, via
this route, also modulate higher-cognitive processes. That is, neural processes that generate
basic emotional states (i.e., primary process of feeling) interact with higher neocortical
substrates that integrate cognitive and cultural contributions to emotions in humans (i.e.,
secondary process of learning and thinking as well as tertiary process of thoughts about
thought; Panksepp, 2009, 2010). In support of this interaction, oxytocin administration
has been shown to modulate subcortical regions (e.g., amygdala, basal forebrain structures
such as the bed nucleus and septal areas; Panksepp, 1992) and to alter their connectivity
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with cortical regions (e.g., medial prefrontal, anterior cingulate
cortex, orbitofrontal cortex; Sripada et al., 2013; see Bethlehem
et al., 2013, for an overview). Notably, there is evidence
of widespread effects of oxytocin on the brain’s intrinsic
functioning as well as of task- and context-dependency, as well
as modulations by interindividual variables and sex hormones,
of oxytocin’s effect on brain systems (Bethlehem et al., 2013).
Most people experience declines in certain cognitive
functions as they reach advanced age, including reductions in
learning efficiency, working memory, executive functioning,
and cognitive processing speed. They also tend to experience
greater difficulty with certain socio-affective capacities, whereas
others remain largely intact (Ebner et al., 2013). For example,
the ability to recognize emotions in others declines with age
(Isaacowitz et al., 2007; Ruffman et al., 2008, 2012). In contrast,
emotional problem solving skills (Blanchard-Fields, 2007) and
some emotion-regulatory capacities (Gross et al., 1997; Scheibe
and Blanchard-Fields, 2009; Shiota and Levenson, 2009; Urry
and Gross, 2010) are maintained or even improve with age,
and older compared to young adults report increased frequency
of positive (compared to negative) feelings (Carstensen et al.,
2011).
Surprisingly, though a growing literature suggests that
oxytocin enhances attention to and understanding of emotions,
research on oxytocin has not been linked to the literature
on social and affective aging and close to nothing is known
about baseline levels of oxytocin and functional changes in
the oxytocin system in aging. Integrating these lines of work
appears particularly fruitful, given that oxytocin’s socio-affective
effects show inter-individual variations by level of proficiency
(Bartz et al., 2011). That is, more impaired, compared to less
impaired, individuals appear to benefit more from oxytocin
administration. Relatedly, there may be a point beyond which
oxytocin cannot further improve socio-affective abilities. We
therefore argue that oxytocin’s effects may vary across age,
as young and older adults differ in their level of socio-
affective proficiency such as pertaining to emotion recognition
or emotion-regulatory skills. In addition, as recently summarized
(Ruffman et al., 2008; Scheibe and Carstensen, 2010; Samanez-
Larkin and Carstensen, 2011; Ebner and Fischer, 2014), age-
associated motivational, cognitive, and sensory changes as well
as age-related structural and functional brain changes, including
changes in neurotransmitter concentration and function, may
influence processing of socio-affective information and underlie
age variations in oxytocin’s effects (Ebner et al., 2013, 2015).
Recent studies also strongly suggest sex differences in the
dynamics and actions of the oxytocin system, raising the
possibility that the effects of oxytocin may be differentially
regulated by gonadal steroids or other sex-specific biological
factors (e.g., brain anatomy, neural processing, and/or
endogenous oxytocin levels; Bos et al., 2012; Macdonald,
2013; Kanat et al., 2014; Ebner et al., 2015). Bos et al. propose
a model for the neuroendocrine regulation of human social-
emotional behavior according to which steroid hormones
(e.g., testosterone, estrogen) and neuropeptides (e.g., oxytocin,
vasopressin) interact in their effect on brain function and
behavior in a dynamic variation by environmental context
(e.g., perceptions of a social situation as challenging vs. safe;
see also van Anders et al., 2011, for a similar construal). This
mechanistic explanation is in line with a broad animal literature
documenting distinct roles of oxytocin in males and females (see
Macdonald, 2013, for references) as well as increasing evidence
suggesting sex-opposing effects of oxytocin on amygdala
reactivity (Guastella et al., 2009; Domes et al., 2010; Rupp
et al., 2014), risk taking (Patel et al., 2014), emotional empathy
(Hurlemann et al., 2010), cardiovascular responses to social
stressors (Kubzansky et al., 2012), and kinship and competition
recognition in humans (Fischer-Shofty et al., 2013).
Importantly, the majority of current research on oxytocin’s
socio-affective effects has been conducted in young men, while
examination of oxytocin’s socio-affective effects in women and
older adults have largely been neglected (see Barraza et al., 2013;
Campbell et al., 2014, for exceptions of recent studies that also
comprised older adults). Thus, using a double-blind, placebo-
controlled between-group design, the present study went beyond
previous research by testing effects of oxytocin on meta-mood,
a socio-affective capacity that shows age and sex differences,
within a single experimental protocol in young and older men
and women.
Meta-mood refers to the awareness about one’s capability
to notice and think about one’s own feelings (attention to
feelings) and the understanding of one’s own mood (clarity
of feelings; Salovey et al., 1995), and can be conceptualized as
a result of interrelated primary (feeling), secondary (learning
and thinking), and tertiary (thoughts about thought) affect
processes (Panksepp, 2010). While the majority of previous
research has examined oxytocin’s effect on emotion perception
in others (but see Cardoso et al., 2014), in the present study
we examined its effects on subjective emotion perception in
the self. We hypothesized that oxytocin’s effect on meta-
mood would vary by participant age and sex. In particular,
based on evidence of age and sex differences in meta-mood
and emotion-regulatory skills (Gross et al., 1997; Thayer
et al., 2003; Urry and Gross, 2010; Fernández-Berrocal et al.,
2012), we expected beneficial effects of oxytocin on meta-
mood to be most pronounced in older men, as the group
characterized by the lowest level of socio-affective competence,
when compared to young men and women. In contrast, we
expected the effects of oxytocin to be least pronounced in
older women, as the group characterized by the highest level of
socio-affective competence, when compared to young women
and men. We also expected oxytocin’s effects to be less
pronounced in young women than young men, given that young
women typically show higher socio-affective competence than
young men.
Materials and Methods
Participants
Forty-eight young (M = 22.4 years, SD = 2.97, 18–22 years, 48%
female) and 54 older (M = 71.2 years, SD = 4.92, 63–81 years,
56% female) white, English-speaking volunteers participated in
the study. Participants were recruited through mailouts and
fliers in the community and on campus and were screened for
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physical and cognitive health via self-report during an initial
phone contact and an on-campus visit. Among the exclusion
criteria were pregnancy, as confirmed with pregnancy testing,
breastfeeding, psychological disorder, severe or progressive
medical illness, known allergies to the preservatives in the nasal
spray, and excessive smoking or drinking. Under the supervision
of a clinical practitioner participants underwent a blood test
(i.e., basic metabolic panel) and a health review covering all
major bodily systems. Participants were instructed to stay well
hydrated before their visit but to abstain from smoking, caffeine,
alcohol, and use of recreational drugs in the 24 h, and from food,
exercise, or engagement in sexual activity in the 2 h, leading up to
their appointment. All test sessions took place in the mornings,
typically starting around 8AM.
We recorded date of last menstruation and use of oral
contraception and hormone replacement therapy. All older
women were postmenopausal, all young women were
premenopausal. Ten young women were in the follicular
phase of their menstrual cycle. One older man and one older
woman were currently on hormone replacement therapy. Seven
young women were on oral contraception.
Older participants scored≥ 30 on the Telephone Interview for
Cognitive Status (Brandt et al., 1988); only 0.08% of all contacted
older adults were excluded based on this criterion. Age groups
were comparable in educational level. Self-reported physical
functioning was good, and visual-processing speed and short-
term verbal memory were comparable to typical performance
levels in these age groups.
Procedure
This data collection was part of a larger project. Participants
underwent a screening phase a few days to a few weeks before
the full study visit, which was partly phone-based and partly in
person, and during which their overall health status was reviewed
via self-report, and a blood draw was conducted. Twenty-six
young (46% female) and 27 older (56% female) participants were
randomly assigned to self-administer via a nasal spray 24 IUs
(one puff per nostril) of oxytocin. Twenty-two young (50%
female) and 27 older (56% female) participants self-administered
a placebo that contained all ingredients with the exception of the
oxytocin.
Numbers of young women in the follicular (oxytocin: 42%;
placebo: 50%) compared to the luteal (oxytocin: 58%; placebo:
50%) phase of their menstruational cycle did not significantly
differ for the two treatment groups (χ2 = 0.153, p = 0.696).
Also, the two treatment groups were statistically comparable
with respect to numbers of young women on oral contraceptives
(oxytocin: 33%; placebo: 40%) compared to those not on
oral contraceptives (oxytocin: 67%; placebo: 60%; χ2 = 0.105,
p = 0.746). Furthermore, to determine comparability of the
two randomly assigned treatment groups in terms of mood
prior to treatment, participants indicated their positive and
negative mood in the present moment via the brief Positive
Affect Negative Affect Scale (PANAS; Watson et al., 1988).
In particular, participants indicated on a scale ranging from
1 = very slightly or not at all to 5 = extremely for a list of
adjectives (e.g., excited, happy, afraid, alert) how they felt at
the present moment. The treatment groups reported comparable
pre-treatment positive (oxytocin: M = 3.11, SD = 0.09; placebo:
M = 3.26, SD = 0.11; F(1,91) = 0.89, p = 0.35, η2p = 0.01)
and negative (oxytocin: M = 1.21, SD = 0.04; placebo:
M = 1.19, SD = 0.04; F(1,91) = 0.07, p = 0.80, η2p = 0.00)
mood.
Nasal spray administration followed recommendations for
the standardized application of intranasal oxytocin (Guastella
et al., 2013). Approximately 120 min after spray administration,
participants responded to items of the two subscales ‘‘attention
to feelings’’ (e.g., I think about my mood constantly) and ‘‘clarity
of feelings’’ (e.g., I am usually very clear about my feelings) of
the Trait Meta-Mood Scale (TMMS; see Salovey et al., 1995 for
item inventory), on a scale ranging from 1 = strongly disagree
to 5 = strongly agree. The TMMS is an introspective measure
of meta-cognition associated with participants’ feelings and
emotions. It allows for reliable measurement of stable attitudes
and enduring qualities of the reflective experience of mood with
Cronbach’s α ranging between 0.7 and 0.9 for the subscales
(Salovey et al., 1995, 2002). In line with the literature (Salovey
et al., 1995), the two subscales were uncorrelated (p > 0.05),
supporting the notion that they capture largely distinct facets of
meta-mood. Written informed consent was obtained following
a study description. The study protocol was approved by the
Institutional Review Board at University of Florida.
Examination of variable distributions indicated that one
young man, one young woman, and one older man were
outliers (based on 1.5 × interquartile range as defined in IBM
SPSS Statistics 22) on the clarity subscale within their age
(young, older) and treatment (oxytocin, placebo) group and were
therefore excluded from subsequent analyses. One older woman
did not fill in the questionnaire.
Results
Mean scores in the attention and clarity subscales were examined
in respective 2 (age: young, older) × 2 (sex: male, female) ×
2 (treatment: oxytocin, placebo) univariate analyses of variance
(ANOVAs). For significant interactions we conducted follow-up
tests.
For attention, the effect of age (F(1,90) = 9.23, p = 0.00,
η2p = 0.09), sex (F(1,90) = 4.46, p = 0.04, η2p = 0.05), and the
age × sex × treatment interaction (F(1,90) = 5.17, p = 0.02,
η2p = 0.06), were significant. That is, overall, young (M = 3.71,
SD = 0.68) compared to older (M = 3.30, SD = 0.66) participants,
as well as women (M = 3.65, SD = 0.71) compared to men
(M = 3.37, SD = 0.65) reported more attention to feelings.
However, as depicted in Figure 1, the significant three-way
interaction qualified these main effects. In particular, follow-up
analyses conducted separately in young and older participants
showed that the sex × treatment interaction was not significant
in young participants (F(1,42) = 1.05, p = 0.31, η2p = 0.02), while
it was significant in older participants (F(1,48) = 5.09, p = 0.03,
η2p = 0.10): in contrast to older women, oxytocin relative to
placebo increased attention to feelings in older men. In addition,
in women there was a significant age × treatment interaction
(F(1,47) = 4.08, p = 0.049, η2p = 0.080), in that in young women
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FIGURE 1 | Participant scores in the attention to feelings subscale of
the TMMS in the oxytocin and placebo conditions, as a function of
participant age and sex, with error bars representing mean standard
errors. ∗p > 0.05.
oxytocin relative to placebo enhanced attention to feelings, while
in older women oxytocin relative to placebo reduced it. There was
no age × treatment interaction among men.
For clarity the effect of age (F(1,90) = 11.89, p = 0.00, η2p = 0.12)
and the age × treatment interaction (F(1,90) = 4.93, p = 0.03,
η2p = 0.052) were significant, while the age × sex × treatment
interaction only approached significance (F(1,90) = 3.06, p = 0.08,
η2p = 0.03). That is, overall, older (M = 3.73, SD = 0.78) compared
to young (M = 3.17, SD = 0.82) participants reported more
clarity of feelings. However, the significant age × treatment
interaction for clarity suggested that young participants in the
oxytocin group reported more clarity of feelings than young
participants in the placebo group, while the reverse held true
for older participants. Similar to the findings for the attention
subscale, an analysis conducted separately for men and women
suggested that this age × treatment interaction only held in
women (F(1,47) = 8.08, p = 0.01, η2p = 0.15) but not in men
(F(1,43) = 0.11, p = 0.74, η2p = 0.00). That is, oxytocin relative to
placebo enhanced clarity in young women but reduced it in older
women. Results for clarity are summarized in Figure 2.
The pattern of findings remained stable when controlling,
in covariate analyses (ANCOVAs), for pre-treatment mood
assessed on the day of the full visit as well as processing speed,
short-term verbal memory, and years of education, and use of
oral contraceptive while in the study. Also, the general pattern of
findings was comparable when excluding older participants on
hormone replacement therapy or young women in the follicular
phase, respectively.
Discussion
There have been recent calls for systematic examination of sex
and age influences on oxytocin level and function in brain
and behavior (Bethlehem et al., 2013; Ebner et al., 2013, 2015;
Huffmeijer et al., 2013). These calls were based on evidence that
females have higher plasma oxytocin levels than males (Carter,
2007) as well as a growing literature suggesting possibly opposing
effects of oxytocin on socio-affective functioning in women
vs. men (see Macdonald, 2013). Also, currently, knowledge is
lacking of possible differences in plasma oxtyocin levels as well
as oxytocin function in human aging and preclinical evidence on
FIGURE 2 | Participant scores in the clarity of feelings subscale of the
TMMS in the oxytocin and placebo conditions, as a function of
participant age and sex, with error bars representing mean standard
errors. ∗p > 0.05.
aging effects on the oxytocin system is still scare and quite mixed
(Fliers and Swaab, 1983; Wierda et al., 1991; Arletti et al., 1995;
Arsenijevic et al., 1995; Melis et al., 1995; Parker et al., 2010). The
present paper constitutes a first response to these recent calls for
systematic examination of sex and age influences on oxytocin
level and function (Bethlehem et al., 2013; Ebner et al., 2013,
2015; Huffmeijer et al., 2013).
To our knowledge, together with the recent study by Campbell
et al. (2014), our study is the first to show an age- by sex-
modulatory role of oxytocin on socio-affective functioning and
thus importantly qualifies previous research that exclusively
focused on young, and largely on male, participants. Results
from our study offer a fruitful empirical ground on which to
further explore aging effects in the oxytocin system (Ebner et al.,
2013, 2015; Huffmeijer et al., 2013). In particular, our findings
suggest that self-administered intranasal oxytocin exerts age- and
sex-specific effects on meta-mood, that is a person’s awareness
about the capability to notice and think about his/her feelings
and to understand them. In contrast to older women, older men
with regard to attention to feelings particularly benefitted from
oxytocin treatment. This result points in the same direction as
evidence from Campbell et al. (2014) who showed improved
emotion recognition skills by oxytocin in older men but not older
women. It is possible that oxytocin enhances communication
between brain regions associated with socio-affective processing
and this increased neurotransmission may be beneficial to those
who are in most need (i.e., older men; Gross et al., 1997;
Fernández-Berrocal et al., 2012). The sex differences in older
adults are also interesting when linked to work by Rilling et al.
(2014) that oxytocin treatment may render neural responses of
men more similar to those of women in the placebo group.
However, Rilling et al. examined effects in young adults only,
while the present study showed sex difference in older adults.
In line with our Age-Related Genetic, Neurobiological,
Sociobehavioral Model of Oxytocin (AGeNeS-OT) model
(Ebner et al., 2013), an investigation of biological influences,
such as steroids hormones or epigenetic factors related to
the oxytocin receptor gene, that undergo age-related change
and differ between men and women, appears particularly
promising to further describe oxytocin’s differential regulation
of socio-affective processes. As proposed by Bos et al. (2012),
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age and sex differences in neuroendocrine factors (e.g.,
associated with endogenous central and/or peripheral oxytocin
levels, or neurotransmitters levels such as dopamine), in
interaction with differences in gonadal hormones (e.g., estradiol,
testosterone), influence malleability (such as via exogenous
oxytocin administration) of neural connectedness between
subcortical and cortical brain structures, whichmay underlie age-
by-sex variations in oxytocin’s socio-affective effects. Also, while
our understanding of oxytocin receptor expression is nascent,
it is possible that age- and sex-related alterations on oxytocin
receptor expression contribute to the effects observed in our
study. It has been shown that estrogen upregulates oxytocin
production and oxytocin receptor expressivity (Bale and Dorsa,
1997; Vasudevan et al., 2001) in the hypothalamus and other
limbic brain regions. This combined with reduced release of
androgens in older compared to young males may contribute
to a ‘‘ramping up’’ effect of older men’s social and affective
system after exogenous elevation of oxytocin levels via intranasal
administration, and may contribute to older males’ greater
attention to their own feelings in the oxytocin compared to
the placebo group. Of note, the present study did not directly
control for the influence of levels of gonadal hormones on
the reported effects (Domes et al., 2010; Lischke et al., 2012).
However, the observed pattern of findings remained after control
for self-reported use of hormone replacement therapy, use of oral
contraceptives, and menstrual cycle. Future studies, that collect
hormone data levels in addition to neuropeptide levels and use
brain imaging while men and women of different ages attend
to their own feelings and process emotional information, will
have to confirm possible interactive effects of hormones and
neuropeptides on brain function and behavior.
Our data did not confirm previous evidence suggesting
particularly greater meta-mood in older women compared to
men and young women (Gross et al., 1997; Fernández-Berrocal
et al., 2012). The finding, from our post hoc analysis, that oxytocin
relative to placebo enhanced meta-mood in young women but
reduced it in older women is in line with growing evidence of
possible negative effects of intranasal oxytocin on socio-affective
functioning under certain circumstances. For example, Cardoso
et al. (2014) showed that intranasal oxytocin administration can
impair emotion recognition in individuals who do not show
deficits in emotion identification by promoting ‘‘oversensitivity’’
to emotion cues. Our findings also follow suggestions that the
effects of oxytocin may be task- or context-dependent as well as
modulated by interindividual differences (Panksepp, 1992; Bartz
et al., 2011; Bos et al., 2012).
Young men did not exhibit a significant effect of oxytocin
administration on meta-mood. While the majority of prior
studies that showed beneficial effects of intranasal oxytocin in
young men examined others-related cognition, such as face
memory or trust perceptions, the present study focused on
internally oriented meta-cognitive emotion evaluation, which
may remain unaffected by oxytocin in young men. The time
period between drug and questionnaire administration in our
study was about 120 min, suggesting that effects of intranasal
oxytocin administration may last longer than was previously
assumed (Guastella et al., 2013; Paloyelis et al., 2014). However,
it is possible that drug effects in the present study may not have
lasted in youngmen resulting in null effects for this group. Future
systematic investigation of age and sex differences in the timing
of drug absorption and peak levels is warranted to confirm this
speculation.
The current study provides first intriguing evidence of an
age- by sex-neuromodulatory role of oxytocin on trait meta-
mood. Neuropeptides like oxytocin only degrade slowly in the
brain, which gives them the potential to have effects over longer
distances involving different brain regions in a dynamic fashion
(Bethlehem et al., 2013). This may imply that effects of oxytocin
on more general trait meta-mood may differ from effects on
more spontaneous state meta-mood. Also, previous work has
suggested that the TMMS is related to more objective behavioral
measures of emotional competence such as psychophysiological
measures of adaptive coping (e.g., reduced cortisol release and
blood pressure during acute stress; Salovey et al., 2002). Going
beyond introspection as applied in the present study, it would be
interesting to address in future extensions of our research effects
of intranasal oxytocin on behavioral measures of emotional
competence such as pertaining to emotion-regulatory capacities
or emotional problem solving abilities in young and older men
and women (Campbell et al., 2014).
Importantly, pre-treatment positive and negative mood was
comparable in our randomly assigned treatment groups and
controlling for mood did not change the pattern of findings of
oxytocin’s age and sex effects on meta-mood. However, as the
current study did not assess mood after oxytocin administration,
it cannot rule out that oxytocin may have affected current mood,
maybe in an age- and sex-differential manner, which is an
interesting topic to address in future research.
In conclusion, we provide intriguing first evidence that
oxytocin’s effects on meta-mood vary by age and sex. To date,
close to nothing is known about the effects of intranasal oxytocin
on social and emotional functions in young and older men and
women (see Campbell et al., 2014, for an exception). Independent
future research needs to replicate our results and determine
the extent to which these modulatory effects are reflected in
brain processes, such as for example associated with age and
sex differences in strength of functional connectivity involved in
socio-affective processing. Accumulating evidence suggests that
oxytocin exemplifies one of the shared biochemical substrates
that serve socio-affective functions in both humans and non-
human animals and supports the notion that complex social
cognition and affective functioning and its neuromodulatory
control in humans can be traced back evolutionarily (Donaldson
and Young, 2008; Panksepp, 2009; Pedersen et al., 2014; Ebner
et al., in press). Focused cross-species comparisons in future
research on oxytocin function promises great potential to unravel
the principles by which the neural and genetic substrates of
emotionality operate in mammalian brains, and to determine
age- and sex-specific variations therein. We hope that these
preliminary findings will spur future replication of oxytocin’s
modulatory function in age- and sex-heterogeneous samples,
with a particular focus on identification of neurobiological
factors that contribute to differences in socio-affective aging and
among men and women.
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